Media-OutReach Newswire Li Ka Shing Foundation and Temasek Trust Jointly Commit S$12 Million to Acquire Systems and Advance Clinical Trial for Innovative Histotripsy Cancer Therapy in Singapore
Media-OutReach Newswire Immuno Cure Biotech Presents Promising Results on Phase I Clinical Trial of a Therapeutic HIV DNA Vaccine
Media-OutReach Newswire Policy Address by Hong Kong SAR’s Chief Executive John Lee: Reform for Enhancing Development and Building Our Future Together
Media-OutReach Newswire NCS Partners Global Players To Advance A Collaborative, Empowered and Safer Tomorrow
Media-OutReach Newswire HKU’s innovative research novelties excel at 48th International Exhibition of Inventions of Geneva
2023 VinFuture Special Prize Laureate Prof. Daniel Drucker: Ample room remains for innovation in GLP-1 therapies 2.